Technologies

REPURPOSING OF FDA-APPROVED DRUGS FOR INHIBITING THE INFLAMMATORY PROCESS ASSOCIATED WITH CORONA VIRUS INFECTION

Type: Pharmaceuticals
Sector: Infectious Diseases-Microbiology-Virology

Prof. Amnon Peled and his team have screened 1322 FDA-approved drugs for their ability to treatCOVID-19 inducedPneumonia using a unique High Throughput Screening assay developed at Prof. Peled's lab.

Several drugs were selected to undergo a phase IIclinical trialat Hadassah and other medicalcenters.

Share this page on:

Facebook Twitter LinkedIn Email

Researcher/s:

Prof. Amnon Peled

Contact Info:

Tal Almog